MAP4Ks Inhibition Promotes Retinal Neuron Regeneration from Müller Glia in Adult Mice
Houjian Zhang,Yuli Guo,Yaqiong Yang,Yuqian Wang,Youwen Zhang,Jingbin Zhuang,Yuting Zhang,Mei Shen,Jiankai Zhao,Rongrong Zhang,Yan Qiu,Shiying Li,Jiaoyue Hu,Wei Li,Jianfeng Wu,Haiwei Xu,Steven J. Fliesler,Yi Liao,Zuguo Liu
DOI: https://doi.org/10.1038/s41536-023-00310-6
IF: 14.404
2023-01-01
npj Regenerative Medicine
Abstract:Abstract Mammalian Müller glia (MG) possess limited regenerative capacities. However, the intrinsic capacity of mammalian MG to transdifferentiate to generate mature neurons without transgenic manipulations remains speculative. Here we show that MAP4K4, MAP4K6 and MAP4K7, which are conserved Misshapen subfamily of ste20 kinases homologs, repress YAP activity in mammalian MG and therefore restrict their ability to be reprogrammed. However, by treating with a small molecule inhibitor of MAP4K4/6/7, mouse MG regain their ability to proliferate and enter into a retinal progenitor cell (RPC)-like state after NMDA-induced retinal damage; such plasticity was lost in YAP knockout MG. Moreover, spontaneous trans-differentiation of MG into retinal neurons expressing both amacrine and retinal ganglion cell (RGC) markers occurs after inhibitor withdrawal. Taken together, these findings suggest that MAP4Ks block the reprogramming capacity of MG in a YAP-dependent manner in adult mammals, which provides a novel avenue for the pharmaceutical induction of retinal regeneration in vivo.